亿帆医药,002019,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 原料药,58836,14266,44570,75.75%,40.61% 医药服务,85817,65300,20517,23.91%,18.69% 高分子,14580,10489,4091,28.06%,3.73% 医药产品,92546,51967,40579,43.85%,36.97% 亿帆医药,002019,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药服务,148788,109836,38951,26.18%,19.78% 高分子材料,28841,-- ,-- ,--,0% 医药产品,158878,85857,73021,45.96%,37.08% 原料药,126673,41715,84959,67.07%,43.14% 其他(补充),-- ,1089,-- ,--,0% 亿帆医药,002019,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药服务,64326,47617,16709,25.98%,14.81% 原料药,83182,21972,61210,73.59%,54.24% 高分子,14662,10960,3702,25.25%,3.28% 医药产品,70379,39149,31230,44.37%,27.67% 亿帆医药,002019,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 高分子材料,18698,-- ,-- ,--,0% 其他(补充),-- ,1507,-- ,--,0% 医药产品,219492,132671,86821,39.56%,35.41% 原料药,199139,40778,158362,79.52%,64.59% 亿帆医药,002019,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 高分子,8642,5867,2775,32.11%,2.79% 原料药,77037,20097,56940,73.91%,57.22% 医药,100009,60212,39798,39.79%,39.99% 亿帆医药,002019,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 高分子材料,19891,12721,7170,36.05%,4.05% 原料药,112586,30701,81885,72.73%,46.22% 医药产品,217983,129884,88098,40.42%,49.73% 亿帆医药,002019,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1175,124,1051,89.47%,1.26% 高分子材料,9054,6014,3040,33.58%,3.64% 原料药,56235,18097,38139,67.82%,45.66% 医药产品,106704,65410,41293,38.7%,49.44% 亿帆医药,002019,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 高分子材料,21176,15060,6117,28.89%,6.22% 原料药,56597,35005,21592,38.15%,21.95% 医药产品,165719,95078,70642,42.63%,71.83% 亿帆医药,002019,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 化学制药,70858,39959,30899,43.61%,63.91% 其他,97,48,50,51.09%,0.1% 高分子材料,11314,8416,2899,25.62%,6% 中药,8205,5351,2854,34.78%,5.9% 原料药,30759,19628,11130,36.19%,23.02% 其他(补充),578,64,514,88.98%,1.06% 亿帆医药,002019,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 PVB,2590,1876,713,27.54%,1.06% D-泛酸钙,11358,5112,6246,54.99%,9.29% 泌尿系统类,317,250,68,21.29%,0.1% 风湿类,941,461,480,51.01%,0.71% 配送产品,23548,21767,1781,7.56%,2.65% 特定代理,73800,43134,30666,41.55%,45.6% 消化系统类,806,655,150,18.64%,0.22% 呼吸系统类,826,517,309,37.42%,0.46% 皮肤外用类,5921,1995,3926,66.31%,5.84% 进口及分装产品,144,98,46,31.79%,0.07% 原材料新材料其他,204,182,22,10.58%,0.03% PBS,2509,1711,798,31.82%,1.19% 其他(补充),658,14,643,97.81%,0.96% 国产药品代理,31252,15388,15864,50.76%,23.59% EVA,2344,1819,525,22.41%,0.78% 泛醇,2799,1700,1099,39.27%,1.63% 抗感染类,1470,779,691,46.99%,1.03% 心血管类,6948,3751,3197,46.01%,4.75% 医疗器械,67,37,29,44.02%,0.04% 亿帆医药,002019,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),199,-- ,-- ,--,0% 其他,1859,1697,162,8.73%,0.79% EVA,2633,2149,484,18.38%,2.36% PVB,4682,3289,1393,29.75%,6.79% PBS,2332,1926,406,17.41%,1.98% 泛醇,6556,4281,2275,34.7%,11.09% D-泛酸钙,25506,9709,15798,61.94%,77% 亿帆医药,002019,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),253,-- ,-- ,--,0% 其他,2511,2773,-262,-10.44%,-1.35% EVA,6754,5146,1607,23.8%,8.28% PVB,8518,6394,2124,24.94%,10.94% PBS,2924,2252,672,22.97%,3.46% 泛醇,12059,8461,3598,29.84%,18.53% D-泛酸钙,36783,25107,11676,31.74%,60.14% 亿帆医药,002019,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),84,-- ,-- ,--,0% 其他,1215,1216,-1,-0.06%,-0.01% EVA,2038,1525,513,25.19%,5.77% PVB,3550,2687,863,24.3%,9.69% PBS,1681,1471,210,12.5%,2.36% 泛醇,6294,4477,1817,28.87%,20.41% D-泛酸钙,18808,13308,5500,29.24%,61.78% 亿帆医药,002019,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),4595,-- ,-- ,--,0% 其他,2179,2169,10,0.46%,0.07% EVA,7134,5131,2003,28.07%,14.28% PVB,5081,4576,505,9.94%,3.6% PBS,2404,1989,415,17.26%,2.96% 泛醇,10750,8004,2746,25.54%,19.57% D-泛酸钙,32276,23926,8350,25.87%,59.52% 亿帆医药,002019,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 活性炭,84,190,-106,-125.84%,-1.64% 精细化工产品,22918,17204,5714,24.93%,88.62% 高分子材料,4822,3983,840,17.41%,13.02% 其他(补充),4339,-- ,-- ,--,0% 亿帆医药,002019,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),739,-- ,-- ,--,0% 活性炭,883,1352,-469,-53.14%,-4.28% 高分子材料,8194,7752,442,5.39%,4.03% 保健品、药品,-- ,-- ,-- ,--,0% 精细化工产品,39758,28776,10982,27.62%,100.25% 亿帆医药,002019,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,3576,3681,-106,-2.96%,-2.17% D-泛醇,5016,3887,1129,22.52%,23.16% D-泛酸钙,14355,10502,3852,26.84%,79.01% 其他(补充),536,-- ,-- ,--,0% 亿帆医药,002019,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 活性炭,290,469,-179,-61.89%,-1.78% 高分子材料,1229,1014,215,17.51%,2.14% 保健品、药品,208,322,-114,-54.77%,-1.14% 精细化工产品,35784,25657,10127,28.3%,100.78% 亿帆医药,002019,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1487,1554,-67,-4.51%,-1.07% D-泛醇,5700,3729,1971,34.58%,31.41% D-泛酸钙,12673,8301,4372,34.5%,69.66% 亿帆医药,002019,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 高分子材料,85,64,21,24.43%,0.15% 保健品、药品,279,347,-68,-24.54%,-0.51% 精细化工,39361,25844,13517,34.34%,100.35% 亿帆医药,002019,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 高分子材料,8,10,-1,-17.76%,-0.02% 医药、保健品,156,223,-68,-43.58%,-1.11% 精细化工产品,19272,13073,6199,32.17%,101.13% 亿帆医药,002019,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,2986,3002,-16,-0.54%,-0.08% 骨青春乐缘片,605,361,244,40.36%,1.22% 泛醇,7893,5627,2266,28.71%,11.32% D-泛酸钙,36153,18618,17534,48.5%,87.55% 亿帆医药,002019,收入构成,报告日期,2008-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,553,464,89,16.11%,0.58% 骨青春,504,173,331,65.77%,2.17% D-泛醇,4077,2840,1237,30.34%,8.11% D-泛酸钙,24245,10656,13588,56.05%,89.13% 亿帆医药,002019,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医药其他产品,81,59,22,27.2%,0.04% 骨青春乐缘片,806,230,576,71.46%,1.18% 生化其他产品,40,17,23,57.1%,0.05% 羟基乙酸,377,326,51,13.55%,0.1% 左酯,302,106,197,65.06%,0.4% D-泛醇,6084,4133,1951,32.07%,4% D-泛酸钙,68625,22658,45967,66.98%,94.22% 亿帆医药,002019,收入构成,报告日期,2007-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 溶液剂,12,8,4,31.73%,0.02% 骨青春乐缘片,503,180,323,64.19%,1.61% 生化其他产品,14,7,7,48.49%,0.03% 羟基乙酸,265,195,70,26.36%,0.35% 左酯,245,84,161,65.64%,0.8% D-泛醇,3268,1937,1331,40.73%,6.63% D-泛酸钙,29058,10874,18184,62.58%,90.56% 亿帆医药,002019,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 D-泛醇,4459,3141,1319,29.57%,12.04% D-泛酸钙,28351,18719,9632,33.97%,87.96% 亿帆医药,002019,收入构成,报告日期,2006-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 骨青春乐缘片,1733,546,1188,68.53%,14.47% D-泛醇,3741,2650,1091,29.16%,13.29% D-泛酸钙,19903,13973,5930,29.79%,72.24% 亿帆医药,002019,收入构成,报告日期,2006-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,203,78,125,61.73%,2.41% 骨青春乐缘片,1248,375,874,70%,16.81% D-泛醇,2436,1705,730,29.99%,14.05% D-泛酸钙,13400,9932,3468,25.88%,66.73% 亿帆医药,002019,收入构成,报告日期,2006-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,116,39,77,66.51%,2.92% 保健品,718,218,501,69.66%,18.95% 泛醇,1432,1086,347,24.2%,13.13% 泛酸钙,7272,5555,1717,23.61%,65% 亿帆医药,002019,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,47,33,14,30.24%,0.18% 保健品,426,123,303,71.22%,3.76% 生化产品,26459,18717,7742,29.26%,96.06% 亿帆医药,002019,收入构成,报告日期,2005-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,21,16,5,25.36%,0.28% D-泛醇,1264,840,424,33.55%,21.93% D-泛酸钙,6024,4519,1505,24.98%,77.79% 亿帆医药,002019,收入构成,报告日期,2005-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 新洁尔灭,8,8,-0,-5.08%,-0.01% 双氧水,19,14,5,25.63%,0.11% 过氧乙酸,32,27,5,15.01%,0.11% 左内酯销售,172,65,107,62.47%,2.4% D-泛醇销售,2736,1685,1052,38.43%,23.48% D-泛酸钙销售,10434,7124,3310,31.72%,73.91% 亿帆医药,002019,收入构成,报告日期,2005-03-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其它,114,47,67,58.74%,3.74% D-泛醇,1132,728,404,35.69%,22.54% D-泛酸钙,4555,3233,1322,29.02%,73.72% 亿帆医药,002019,收入构成,报告日期,2004-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他产品,110,35,75,68.41%,0.93% D-泛醇,4210,2690,1520,36.1%,18.8% D-泛酸钙,20186,13697,6489,32.15%,80.27% 亿帆医药,002019,收入构成,报告日期,2004-09-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,35,12,23,66.93%,1.11% D-泛醇,1216,832,383,31.54%,18.24% D-泛酸钙,5077,3381,1696,33.4%,80.65% 亿帆医药,002019,收入构成,报告日期,2004-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,27,9,18,67.31%,0.4% D-泛醇,1782,1082,700,39.28%,15.49% D-泛酸钙,9543,5741,3802,39.84%,84.11%